Dalian Fusheng Natural Drug Development

Dalian Fusheng Natural Drug Development is a China-based biopharmaceutical company dedicated to the discovery and production of monomeric drugs from natural medicinal plants. The company achieved significant recognition for developing the Shenyi Capsule, a purified Ginsenoside Rg3 compound that serves as an anti-angiogenic agent for cancer treatment. Approved by the NMPA, this product is utilized as an adjuvant therapy to enhance the efficacy of chemotherapy and radiotherapy while reducing toxicity. Dalian Fusheng maintains a specialized focus on ginsenoside research, exploring various derivatives for their potential in treating solid tumors and improving immune function. The company operates integrated research, development, and manufacturing facilities in Dalian.